• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Baxter Awarded Pandemic Supply Contract From Department of Health

Theresa42

Well-known member
Hat-tip, bgw in MT!

Baxter Awarded Pandemic Supply Contract From Department of Health
Sep 13, 2007
BioPharm Bulletin

Baxter International Inc., (Deerfield, IL, www.baxter.com), has entered into an advanced supply agreement with the Department of Health that contains an option to purchase pandemic influenza vaccine in the event the World Health Organization (WHO) declares a pandemic.

Baxter will manufacture its pandemic vaccine in a serum-free, vero cell-based system, at one of the largest cell culture vaccine facilities in the world. Vaccines produced using this process can be released within approximately 12 weeks, significantly earlier than with traditional egg-based systems. All influenza strains with pandemic potential tested for growth in vero cells have produced replicable high yields, providing the company with the ability to respond to emerging variant pandemic virus strains.

http://www.biopharminternational.co.../ArticleStandard/Article/detail/456516?ref=25
 
Back
Top